Multiple Sclerosis Clinical Trial
— ExergaMSOfficial title:
Effects of a User-centered Exergame Training on Motor and Cognitive Functions in Persons With Multiple Sclerosis: A Pilot Quasi-Randomized Controlled Trial
This study examines the feasibility and preliminary effects of user-centered exergames (video game-based physical exercise) in persons with multiple sclerosis (PwMS). The user-centered exergames were developed within a interdisciplinary team to meet the requirements of the end-users. The individualized exergames were designed for the Dividat Senso, a pressure sensitive plate connected to a personal computer and a frontal screen. This concurrent motor-cognitive training aims to improve motor and cognitive functions in an ecological valid setting. The cognitive functions are triggered by specific stimuli in the game scenarios. The video games are controlled via specific (whole body) movements as steps, weight shifting, jumps, and arm movements. The training focus is mainly on balance and coordination as well as executive functions and attention. Furthermore, the meaningful games (colorful and appealing visuals) were designed to motivate the players to move. Participants are allocated to the either the intervention group or the control group (quasi-randomization). Participants in the intervention group perform 16 training session over a period of 4 to 8 weeks (depending on in- or out-patient). One training session lasts between 15-25 minutes. Since the difficulty of the games is adaptive to the ability level of each participant, they should neither be over- nor under-challenged. Participates in the control group continue their normal daily routine over 8 weeks. Measurements are performed before, in-between, and after the intervention period to assess feasibility parameters as well as motor and cognitive functions in all participants.
| Status | Recruiting |
| Enrollment | 30 |
| Est. completion date | July 31, 2021 |
| Est. primary completion date | July 31, 2021 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 30 Years to 85 Years |
| Eligibility | Inclusion Criteria: - Clinical diagnosis of MS - Able to provide written informed consent and understand instructions - Able to play the exergames by stepping and weight shifting - Able to walk at least 12m with or without walking aid - Visual acuity with correction sufficient to work on a TV screen Exclusion Criteria: - Presence of musculoskeletal conditions that affect training performance - Excessive fatigue that impairs training participation - Exercise intolerance that prevents training participation - Rapidly progressive or terminal illness - Acute or unstable chronic illness |
| Country | Name | City | State |
|---|---|---|---|
| Switzerland | ETH Zürich | Zürich |
| Lead Sponsor | Collaborator |
|---|---|
| Eling DeBruin |
Switzerland,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Other | Training parameters | Training parameters such as level, points, play time per session, type of game and dual task or single task are collected in a training protocol.
The use (always, sometime or not) of the handrail is noted. |
Through intervention completion, 4 to 8 weeks (depending on in- and outpatient) | |
| Other | Training intensity | Training intensity is rated on a 10-point rating scale (1 = very weak, 10 = very,very strong) to assess the perceived cognitive and physical exertion. | Through intervention completion, 4 to 8 weeks (depending on in- and outpatient) | |
| Other | Training progress | The training progress is assessed by video recordings. With these video recordings possible deficiencies or difficulties can be detected. | Through intervention completion, 4 to 8 weeks (depending on in- and outpatient) | |
| Other | Demographic and medical data | The questionnaire assesses general personal information about participants covering general health, medical history and physical activity.
The survey lasts about 10 minutes and is assessed at pre-measurement. |
Through study completion, an average of 20 weeks | |
| Other | Activities-specific Balance Confidence | Activities-specific Balance Confidence (ABC) scale assesses the confidence in doing different activities without losing the balance or becoming unsteady.
The ABC scale consists of 16 items where each item is rated from 0% (not confident) to 100% (very confident) and lasts about 5 minutes and is assessed at pre-measurement. |
Through study completion, an average of 20 weeks | |
| Other | Multiple Sclerosis Impact | The Multiple Sclerosis Impact Scale (MSIS) assesses the physical and psychological impact of MS.
The MSIS consists of 29 items on a 5-point Likert scale, lasts about 10 minutes and is assessed at pre-measurement. |
Through study completion, an average of 20 weeks | |
| Other | Fatigue | The Fatigue Severity Scale (FSSc) assesses the degree of fatigue. The FSSc consists of 9 items on a 7-point Likert scale, lasts about 3 minutes and is assessed at pre-measurement. | Through study completion, an average of 20 weeks | |
| Primary | Feasibility assessed by recruitment rate | Recruitment rate is the number of study participants compared to the number of initial planned participants | Through recruitment completion, an average of 12 weeks | |
| Primary | Feasibility assessed by adherence rate | Adherence rate is the number of attended training sessions compared to the number of planned trainings | Through intervention completion, 4 to 8 weeks (depending on in- and outpatient) | |
| Primary | Feasibility assessed by attrition rate | Attrition rate is the number of dropouts | Through study completion, an average of 20 weeks | |
| Primary | Feasibility assessed by a safety protocol | Safety protocol includes number of adverse events (including serious adverse events) and specific questions about safety issues | Through study completion, an average of 20 weeks | |
| Primary | System Usability | The System Usability Scale interprets the system usability from 1 to 100, similar to a percentage score. A SUS score of at least 70 has to be reached to have an "acceptable" solution (52 = ok, 73 = good, 85 = excellent, 100 = best imaginable).
The SUS consists of 10 items on a 5-point Likert scale and lasts about 3 minutes. The SUS is assessed at post-measurement. |
Through study completion, an average of 20 weeks | |
| Primary | Feasibility, usability and training experience - Semi-structured interview | The semi-structured interview contains pre-defined questions about user's gameplay experiences related to their body, controller, experience, virtual game scenario and safety.
The interview lasts about 20 minutes and is assessed at post-measurement. |
Through study completion, an average of 20 weeks | |
| Secondary | Changes in balance and mobility | Balance and mobility are assessed with the Timed Up and Go Test. Time needed to complete the assessment is recorded.
Test duration is about 5 to 10 minutes and is assessed at pre- and post-measurement. |
Through study completion, an average of 20 weeks | |
| Secondary | Changes in spatio-temporal gait parameters | Gait analysis is conducted under single (walking; normal speed) and dual (walking + counting; normal speed) over 13 meters to assess spatio-temproal gait parameters ((gait speed, step length, gait variability and double support time).
Gait parameters are assessed via the system Physiolog. Test duration is about 10 to 15 minutes and is assessed at pre- and post-measurement. |
Through study completion, an average of 20 weeks | |
| Secondary | Changes in information processing speed | Simple reaction time test is performed on a personal computer recording reaction time [ms] and errors.
Test duration is about 5 minutes and is assessed at pre- and post-measurement. |
Through study completion, an average of 20 weeks | |
| Secondary | Changes in executive functions - inhibition | Flanker test is performed on a personal computer recording reaction time [ms] and errors.
Test duration is about 10 minutes and is assessed at pre- and post-measurement. |
Through study completion, an average of 20 weeks | |
| Secondary | Changes in executive functions - flexibility | Trail Making Test A & B is performed on a personal computer recording reaction time [ms] and errors.
Test duration is about 10 minutes and is assessed at pre- and post-measurement. |
Through study completion, an average of 20 weeks | |
| Secondary | Training experience - Physical Activity Enjoyment Scale | The Physical Activity Enjoyment Scale (PACES) measures enjoyment in physical activity environments.
The PACES consists of 18 bipolar items on a 7-point Likert scale, lasts about 5 minutes, and is assessed after the first and last training session |
Through study completion, an average of 20 weeks | |
| Secondary | Training experience - Flow Short Scale | The Flow Short Scale (FFS) assesses the flow experience for training experiences.
The FSS consists of 13 items on a 5-point Likert scale and lasts about 5 minutes, and is assessed after the first and last training session. |
Through study completion, an average of 20 weeks |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05528666 -
Risk Perception in Multiple Sclerosis
|
||
| Completed |
NCT03608527 -
Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis
|
N/A | |
| Recruiting |
NCT05532943 -
Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis
|
Phase 1/Phase 2 | |
| Completed |
NCT02486640 -
Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
|
||
| Completed |
NCT01324232 -
Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis
|
Phase 2 | |
| Completed |
NCT04546698 -
5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
|
||
| Active, not recruiting |
NCT04380220 -
Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
|
||
| Completed |
NCT02835677 -
Integrating Caregiver Support Into MS Care
|
N/A | |
| Completed |
NCT03686826 -
Feasibility and Reliability of Multimodal Evoked Potentials
|
||
| Recruiting |
NCT05964829 -
Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
|
N/A | |
| Withdrawn |
NCT06021561 -
Orofacial Pain in Multiple Sclerosis
|
||
| Completed |
NCT03653585 -
Cortical Lesions in Patients With Multiple Sclerosis
|
||
| Recruiting |
NCT04798651 -
Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis
|
N/A | |
| Active, not recruiting |
NCT05054140 -
Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis
|
Phase 2 | |
| Completed |
NCT05447143 -
Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis
|
N/A | |
| Recruiting |
NCT06195644 -
Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients
|
Phase 1 | |
| Completed |
NCT04147052 -
iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis
|
N/A | |
| Completed |
NCT03591809 -
Combined Exercise Training in Patients With Multiple Sclerosis
|
N/A | |
| Completed |
NCT03594357 -
Cognitive Functions in Patients With Multiple Sclerosis
|
||
| Completed |
NCT02845635 -
MS Mosaic: A Longitudinal Research Study on Multiple Sclerosis
|